NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/20/20

Biomerica (NASDAQ: BMRA ) -28% . More news on: Biomerica, Inc., Waitr Holdings Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...

3 Penny Stocks Pushing Higher On Thursday Why do people invest in penny stocks ? A history of big breakouts and quick gains have been a major source of interest. Just this week we witnessed the true potential of penny stocks. Case in point, Blue Apron ( APRN-Free Report ) and Biomerica Inc....

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that it will report 2019 fourth quarter and full year financial results after market close on Thursday, March 26, 2...

NovaBay Pharmaceuticals (NYSEMKT: NBY ) has launched  NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Dry wipes are specifically designed for applying Avenova ® to treat dry eye and blepharitis NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces the launch of NovaWipes , a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova ® , on A...

The market is vast with many different options for investors to put money into. You can trade anything from penny stocks to large-cap stocks. When it comes to penny stocks, these are considered to be any equity that trades below $5. The cheap stocks can bring investors large amounts of profits...

NovaBay Pharmaceuticals (NYSEMKT: NBY ) is up  21%  premarket after the launch of NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks...

NovaSight complements Avenova ® Direct for comprehensive internal and external eye health NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaSight ™, a proprietary daily vitamin and mineral supplement specially formulated to support o...

NovaBay Pharmaceuticals, Inc. (NBY) Q3 2019 Results Conference Call November 07, 2019 04:30 PM ET Company Participants Jody Cain - Investor Relations Justin Hall - President and Chief Executive Officer Jason Raleigh - Chief Financial Officer Conference Call Participants Jef...

NovaBay (NYSEMKT: NBY ): Q3 GAAP EPS of -$0.02 beats by $0.06 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...